10/28, 10:12 PM (Source: TeleTrader)
more TeleTrader news

Gilead says revenue up 13% to $7.4 billion in Q3

Gilead Sciences Inc. announced on Thursday that its total revenues reached $7.4 billion in the third quarter of fiscal 2021 after rising 13% compared to the same period a year ago.

Diluted earnings per share (EPS) jumped sevenfold to $2.05, while net income amounted to $2.6 billion in the third three-month period, 633% up from the same trimester last year.

The company upgraded its full-year guidance, and now expects total product sales of between $26 billion and $26.3 billion, compared to $24.4 billion and $25 billion expected previously.

Gilead's stock fell by 1.99% in after-hours trading following the release of the report.

Breaking the News / MS